An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autore principale: | Bristy, Israt Zerin |
---|---|
Altri autori: | Kabir, Md. Tanvir |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
Brac University
2021
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/15619 |
Documenti analoghi
-
Molecules associated with the development of lung cancer
di: Rahman, Adree, et al.
Pubblicazione: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
di: Shabnam, Musharrat
Pubblicazione: (2018) -
Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
di: Paul, Pulock
Pubblicazione: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
di: Mim, Shanzida
Pubblicazione: (2023)